Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15187351 | 0.87 | TSHR (0.46) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL29004685 | 0.87 | TSHR (0.46) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL15187352 | 0.87 | TSHR (0.46) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL15187093 | 0.84 | ALDH1A1 (0.50) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL15183786 | 0.82 | TSHR (0.41) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL15183784 | 0.82 | TSHR (0.41) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL9606840 | 0.81 | TSHR (0.55) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL10044830 | 0.81 | TSHR (0.55) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL17526858 | 0.80 | TSHR (0.48) | TSHRSLC1A1KMT2AMEN1LMNA | |
| SCHEMBL17526925 | 0.80 | TSHR (0.48) | TSHRSLC1A1KMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | claimed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | claimed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | claimed |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | disclosed |
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | A-BIOPHARMA (FR) | 2026-02-03 | — | — | US | disclosed |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2024-05-02 | — | — | US | disclosed |
| EP-4045504-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | Ai-biopharma (FR) | 2022-08-24 | — | — | EP | disclosed |
| US-20170327626-A1 | METHOD FOR PRODUCING RADIATION-CURABLE URETHANE (METH)ACRYLATES | UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF NASA | 2017-11-16 | — | — | US | disclosed |
| EP-1741717-B1 | Metal nanostructures and pharmaceutical compositions | IMEC INTER UNI MICRO ELECTR (BE) | 2009-01-28 | — | — | EP | disclosed |
| US-7420013-B2 | Mixtures of compounds comprising at least two double bonds and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-02 | — | — | US | disclosed |
| US-7250481-B2 | Reacting polyalcohol with at least one ethylenically unsaturated carboxylic acid in the presence of at least one esterification catalyst and of at least one polymerization inhibitor, polymerizing the reaction mixture, in the presence of at least one radical initiator, postcrosslinking, drying | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-31 | — | — | US | disclosed |
| US-7241914-B2 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-10 | — | — | US | disclosed |
| US-20070129564-A1 | Method for the production of (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-07 | — | — | US | disclosed |
| US-20060235141-A1 | Mixtures of compounds comprising at least two double bonds and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-19 | — | — | US | disclosed |
| US-20060052571-A1 | Method for the production of radiation-curable urethane (meth) acrylates | BASF AKITIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| US-20050203268-A1 | Method for producing polyesterpolyols of polyvalent alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-15 | — | — | US | disclosed |
| US-20050176910-A1 | Method for the production of esters of polyalcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-11 | — | — | US | disclosed |
| US-20050148802-A1 | Method for producing polyetherols | BASF AKTIENGESELLSCHAFT | 2005-07-07 | — | — | US | disclosed |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539332-B2 | Anti-viral and hepatic-targeted drugs | HAVCR2, NR1H4, NR1H3 | TSHR 811/4885SLC1A1 1075/4885KMT2A 4322/4885 |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | HAVCR2, NR1H4, NR1H3 | TSHR 1033/4885SLC1A1 1211/4885KMT2A 4167/4885 |
| US-20070129564-A1 | Method for the production of (meth)acrylic acid esters | MMAB, ACR, MCCC2 | TSHR 2304/4885SLC1A1 1996/4885KMT2A 1058/4885 |
| US-20050010065-A1 | Method for producing (meth) acrylic acid esters of polyhydric alcohols | ADH1A, ADH1C, ADH5 | TSHR 2220/4885SLC1A1 2385/4885KMT2A 432/4885 |
| US-20050148802-A1 | Method for producing polyetherols | ADH1A, ADH1C, ADH5 | TSHR 3289/4885SLC1A1 4306/4885KMT2A 509/4885 |
| US-20240139325-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | SLC10A1, HAVCR2, HDGF | TSHR 4110/4885SLC1A1 1223/4885KMT2A 4427/4885 |
| US-20050203268-A1 | Method for producing polyesterpolyols of polyvalent alcohols | ADH1C, ADH1A, ADH5 | TSHR 4473/4885SLC1A1 3230/4885KMT2A 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.